US FDA Guidance Roadblock: Writing Continues, But Publication Has Slowed Or Stopped

 
• By Derrick Gingery
FDA scientists and reviewers continue to write guidances, but the ability to publish them has been curtailed. (Shutterstock)

More from Generics

More from Biosimilars & Generics